Massachusetts Medical Society: COVID-19 Vaccination Recommendations for Children and Teens

COVID-19 Vaccination Recommendations for Children and Teens

The Centers for Disease Control and Prevention (CDC) recommends monovalent COVID-19 primary series vaccination for everyone ages 6 months and older, and bivalent mRNA boosters for everyone ages 5 years and older, if eligible. (see the CDC’s Overview of COVID-19 Vaccines). New: Children ages 6 months through 5 years who previously completed a Moderna primary series are eligible to receive a Moderna bivalent booster 2 months after their final primary series dose.

Both the Moderna COVID-19 Vaccine and Pfizer-BioNTech COVID-19 Vaccine continue to be authorized for primary series administration in individuals six months of age and older.

New: Children 6 months through 4 years of age who have not yet begun their three-dose primary series of the Pfizer-BioNTech COVID-19 Vaccine or have not yet received the third dose of their primary series will now receive the updated (bivalent) Pfizer-BioNTech COVID-19 vaccine as the third dose in their primary series following two doses of the original (monovalent) Pfizer-BioNTech COVID-19 Vaccine.

Novavax's COVID-19 vaccine is authorized for people 12 years and older. The same vaccine product should be used for all doses of the primary series (see CDC’s Interchangeability of COVID-19 vaccine products).

There is currently no authorized COVID-19 vaccine for children younger than age 6 months.

The American Academy of Pediatrics (AAP) also recommends COVID-19 vaccination for all children and adolescents 6 months of age and older who do not have contraindications.

Facebook logoTwitter logoLinkedInYouTube logoInstagram

Copyright © 2023. Massachusetts Medical Society, 860 Winter Street, Waltham Woods Corporate Center, Waltham, MA 02451-1411

(781) 893-4610 | (781) 893-3800 | Member Information Hotline: (800) 322-2303 x7311